These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3816558)

  • 1. Time course of gentamicin serum concentration rebound following hemodialysis.
    Catolico MM; Campbell S; Jones WN; Logan JL
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):46-9. PubMed ID: 3816558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound gentamicin levels after hemodialysis.
    Bauer LA
    Ther Drug Monit; 1982; 4(1):99-101. PubMed ID: 7071910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin pharmacokinetics during hemodialysis.
    Christopher TG; Korn D; Blair AD; Forrey AW; O'Neill MA; Cutler RE
    Kidney Int; 1974 Jul; 6(1):38-44. PubMed ID: 4417700
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gentamicin pharmacokinetics during hemodialysis].
    Takasugi M; Hasegawa O; Soejima M; Yu K; Muta T; Matsuura K; Nakashima Y; Kuroiwa A; Kunifuji Y; Nakamura T
    Nihon Jinzo Gakkai Shi; 1984 Nov; 26(11):1509-19. PubMed ID: 6533375
    [No Abstract]   [Full Text] [Related]  

  • 6. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
    Amin NB; Padhi ID; Touchette MA; Patel RV; Dunfee TP; Anandan JV
    Am J Kidney Dis; 1999 Aug; 34(2):222-7. PubMed ID: 10430966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.
    Sowinski KM; Magner SJ; Lucksiri A; Scott MK; Hamburger RJ; Mueller BA
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):355-61. PubMed ID: 18235142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis urea rebound: the effect of increasing dialysis efficiency.
    Spiegel DM; Baker PL; Babcock S; Contiguglia R; Klein M
    Am J Kidney Dis; 1995 Jan; 25(1):26-9. PubMed ID: 7810527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin pharmacokinetics during slow daily home hemodialysis.
    Manley HJ; Bailie GR; McClaran ML; Bender WL
    Kidney Int; 2003 Mar; 63(3):1072-8. PubMed ID: 12631090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of ampicillin and gentamicin by hemofiltration.
    Kraft D; Lode H
    Klin Wochenschr; 1979 Feb; 57(4):195-6. PubMed ID: 423486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute massive gentamicin intoxication in a patient with end-stage renal disease.
    Lu CM; James SH; Lien YH
    Am J Kidney Dis; 1996 Nov; 28(5):767-71. PubMed ID: 9158219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound following hemodialysis of cimetidine and its metabolites.
    Ziemniak JA; Cersosimo RJ; Russo J; Moran DM; Kablitz C; Schentag JJ
    Am J Kidney Dis; 1984 May; 3(6):430-5. PubMed ID: 6720687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum gentamicin level after intratracheal application in ventilated patients with normal and reduced kidney function].
    Schulz E; Busse FW; Strasburger C; Herhahn J; Wood WG; Sack K
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1964-7. PubMed ID: 6653435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of gentamicin in horses: concentrations in serum, urine, and synovial fluid and evaluation of renal function.
    Beech J; Kohn C; Leitch M; Weinstein AJ; Gallagher M
    Am J Vet Res; 1977 Jul; 38(7):1085-7. PubMed ID: 883716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis on serum concentration of isepamicin in a patient with endstage renal failure.
    Kuranari M; Nawata T; Sato Y; Sakata T; Kodama Y; Takeyama M
    Ann Pharmacother; 1993 Oct; 27(10):1284-5. PubMed ID: 8251702
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of serum creatinine concentration and gentamicin half-life.
    Cutler RE; Gyselynck AM; Fleet WP; Forrey AW
    JAMA; 1972 Feb; 219(8):1037-41. PubMed ID: 5066760
    [No Abstract]   [Full Text] [Related]  

  • 19. Determining gentamicin dosage in infants and children with renal failure.
    Sirinavin S; McCracken GH; Nelson JD
    J Pediatr; 1980 Feb; 96(2):331-4. PubMed ID: 7351608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.
    Létourneau-Saheb L; Lapierre L; Daigneault R; Prud'Homme M; St-Louis G; Serois G
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):116-20. PubMed ID: 844930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.